Prognosis of apical hypertrophic cardiomyopathy in patients with an implantable cardioverter defibrillator

Back

ESC Premium Access

Prognosis of apical hypertrophic cardiomyopathy in patients with an implantable cardioverter defibrillator

Session: Congress committee e-posters choice in arrhythmias and device therapy

Topic: Hypertrophic Cardiomyopathy

Speaker: Doctor M. Nakano (Chiba, JP)

Event: ESC Congress 2021 - The Digital Experience

Congress Presentation

Add to my library

About the speaker

Doctor Miyo Nakano

Chiba University Graduate School of Medicine, Chiba (Japan)

0 follower

23 more presentations in this session

Left atrial dysfunction still exists in patients who obtain normal left atrial volume after successful ablation of atrial fibrillation.

Speaker: Doctor H. Kawakami (Toon, JP)

Access

Abstract

Slides

Same day discharge after atrial fibrillation ablation is feasible and safe. Results of a prospective study in 1015 patients

Speaker: Mr M. Viezelis (Odense, DK)

Access

Abstract

Slides

Benefits of early intervention with catheter ablation in patients with atrial fibrillation

Speaker: Doctor S. Mohanty (Austin, US)

Access

Abstract

Slides

Cryoballoon ablation of atrial fibrillation in low and medium volume hospitals - experiences of the German REGIONAL registry

Speaker: Doctor J. Michaelsen (Lingen, DE)

Access

Abstract

Slides

Accuracy comparison of the new and previous Kodex occlusion tool software versions to assess pulmonary vein occlusion in atrial fibrillation cryoablation

Speaker: Doctor M. Polselli (Rome, IT)

Access

Abstract

Slides

Access the full session

Congress committee e-posters choice in arrhythmias and device therapy

Speakers: Doctor M. Nakano, Doctor H. Kawakami, Mr M. Viezelis, Doctor S. Mohanty, Doctor J. Michaelsen...

Access

About the event

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources